Reporte zur Charge UT71151A

Symptomtext

patient received 2 doses of the Fluzone Quadrivalent prefilled syringe 10 minutes apart yesterday with no specific side effects or symptoms; Initial information regarding an unsolicited valid non-serious case received from a healthcare professional on 29-Dec-2020. This case involves a 11-year-old male patient who received 2 doses of the INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] prefilled syringe 10 minutes apart yesterday with no specific side effects or symptoms (lot UT71151A, expiration date: 30-Jun-2021) for prophylactic vaccination (extra dose administered). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown. This was an actual medication error case due to the event extra dose administered (latency: on the same day). At the time of reporting, no adverse event was reported. Disclaimer: this suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in directive 2001/83/ec and module VI of the good Pharmacovigilance practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. There will be no information available regarding batch number in this case.